EP1796610A4 - Systeme therapeutique transdermique pour la maladie de parkinson - Google Patents

Systeme therapeutique transdermique pour la maladie de parkinson

Info

Publication number
EP1796610A4
EP1796610A4 EP05802679A EP05802679A EP1796610A4 EP 1796610 A4 EP1796610 A4 EP 1796610A4 EP 05802679 A EP05802679 A EP 05802679A EP 05802679 A EP05802679 A EP 05802679A EP 1796610 A4 EP1796610 A4 EP 1796610A4
Authority
EP
European Patent Office
Prior art keywords
parkinson
disease
therapeutic system
transdermal therapeutic
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05802679A
Other languages
German (de)
English (en)
Other versions
EP1796610A2 (fr
Inventor
Marina Braun
Willi Cawello
Eric B Foster
Thomas Lauterbach
Hans-Michael Wolff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schwarz Pharma Inc
Original Assignee
Schwarz Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwarz Pharma Inc filed Critical Schwarz Pharma Inc
Publication of EP1796610A2 publication Critical patent/EP1796610A2/fr
Publication of EP1796610A4 publication Critical patent/EP1796610A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
EP05802679A 2004-09-29 2005-09-29 Systeme therapeutique transdermique pour la maladie de parkinson Withdrawn EP1796610A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61376104P 2004-09-29 2004-09-29
US61376004P 2004-09-29 2004-09-29
PCT/US2005/035257 WO2006039532A2 (fr) 2004-09-29 2005-09-29 Systeme therapeutique transdermique pour la maladie de parkinson

Publications (2)

Publication Number Publication Date
EP1796610A2 EP1796610A2 (fr) 2007-06-20
EP1796610A4 true EP1796610A4 (fr) 2012-12-05

Family

ID=36143101

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05802679A Withdrawn EP1796610A4 (fr) 2004-09-29 2005-09-29 Systeme therapeutique transdermique pour la maladie de parkinson

Country Status (3)

Country Link
EP (1) EP1796610A4 (fr)
JP (1) JP2008514376A (fr)
WO (1) WO2006039532A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10361258A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
JPWO2015129527A1 (ja) 2014-02-27 2017-03-30 株式会社 メドレックス プラミペキソールを含有する神経変性疾患の治療用貼付剤

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049852A1 (fr) * 1998-03-30 1999-10-07 Lts Lohmann Therapie-Systeme Ag Systeme therapeutique transdermique contenant un agoniste d2 servant a traiter le syndrome parkinsonien, et son procede de production
EP1325742A1 (fr) * 2001-05-08 2003-07-09 Schwarz Pharma Ag Système thérapeutique transdermique amélioré pour le traitement de morbus Parkinson
EP1344522A1 (fr) * 2001-05-08 2003-09-17 Schwarz Pharma Ag Système thérapeutique transdermique pour l'obtention de taux plasmatiques élevés de rotigotine dans le traitement de morbus Parkinson
EP1386605A1 (fr) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Systeme transdermique ameliore pour l'administration de rotigotin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885308A (en) * 1984-08-13 1989-12-05 Nelson Research & Development Co. Method and compositions for treatment of parkinsonism syndrome in mammals
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
US6448303B1 (en) * 2000-12-29 2002-09-10 National Starch And Chemical Investment Holding Corporation Hot melt adhesives for dermal application
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
DE10261696A1 (de) * 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049852A1 (fr) * 1998-03-30 1999-10-07 Lts Lohmann Therapie-Systeme Ag Systeme therapeutique transdermique contenant un agoniste d2 servant a traiter le syndrome parkinsonien, et son procede de production
EP1325742A1 (fr) * 2001-05-08 2003-07-09 Schwarz Pharma Ag Système thérapeutique transdermique amélioré pour le traitement de morbus Parkinson
EP1344522A1 (fr) * 2001-05-08 2003-09-17 Schwarz Pharma Ag Système thérapeutique transdermique pour l'obtention de taux plasmatiques élevés de rotigotine dans le traitement de morbus Parkinson
EP1386605A1 (fr) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Systeme transdermique ameliore pour l'administration de rotigotin

Also Published As

Publication number Publication date
WO2006039532A2 (fr) 2006-04-13
EP1796610A2 (fr) 2007-06-20
JP2008514376A (ja) 2008-05-08
WO2006039532A3 (fr) 2006-07-13

Similar Documents

Publication Publication Date Title
IL250734A0 (en) Transdermal therapeutic system
HUS1500043I1 (hu) Eljárások Parkinson-kór kezelésére
HK1124534A1 (en) Therapeutic agent for heart disease
EP2011513A4 (fr) Agents thérapeutiques employés dans le cadre de la maladie d'alzheimer et du cancer
GB0403780D0 (en) Therapeutic agents
PL1858496T3 (pl) Poprzezskórny układ terapeutyczny do aplikowania środków przeciwbólowych
EP1796610A4 (fr) Systeme therapeutique transdermique pour la maladie de parkinson
EP1806137A4 (fr) Agent thérapeutique contre les maladies glomérulaires
HK1139064A1 (en) Therapeutic agent for meniere's disease
IL281624B1 (en) Ultrasound system for medical treatment
EP1908467A4 (fr) Agent thérapeutique dérivé de l'herpèsvirus contre la douleur
EP1719514A4 (fr) Medicament contre la douleur
GB0425854D0 (en) Therapeutic treatment
EP1863510A4 (fr) Méthodes de traitement de la maladie de parkinson
GB0410101D0 (en) Parkinson's disease
EP1900363A4 (fr) Agent thérapeutique contre la douleur
EP1790338A4 (fr) Agent thérapeutique pour un trouble de type kératoconjonctivite
EP1757603A4 (fr) Agent thérapeutique pour une affection de kératoconjonctivite
GB0427882D0 (en) Therapeutic uses for honey
GB0505237D0 (en) Pharmacological drug therapy for alzheimer's disease
GB0408752D0 (en) Therapeutic treatment
GB0403779D0 (en) Therapeutic agents
GB0402918D0 (en) Therapeutic agents
GB0400196D0 (en) Therapeutic agents
AU2004907196A0 (en) Use of Naltrexone for Treating Alzheimer's Disease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070502

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: HR MK

RAX Requested extension states of the european patent have changed

Extension state: MK

Payment date: 20070502

Extension state: HR

Payment date: 20070502

A4 Supplementary search report drawn up and despatched

Effective date: 20121105

RIC1 Information provided on ipc code assigned before grant

Ipc: A61F 13/02 20060101AFI20121029BHEP

Ipc: A61K 31/381 20060101ALI20121029BHEP

Ipc: A61K 9/70 20060101ALI20121029BHEP

Ipc: A61F 13/00 20060101ALI20121029BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130604